Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation

Nicotine and Tobacco Research

Volumn 17, Issue 4, 2014, Pages 407-421

  Weinberger, Andrea H ^a,b,c,f   Smith, Philip H ^b,f   Allen, Sharon S ^b,f   Cosgrove, Kelly P ^d,f   Saladin, Michael E ^b,f   Gray, Kevin M ^e,f   Mazure, Carolyn M ^b,f   Wetherington, Cora Lee ^e,f   Mckee, Sherry A ^b,c,f  

^a YESHIVA UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE CANCER CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; NICOTINE; OVARIAN HORMONE; PROGESTERONE; SEX HORMONE; UNCLASSIFIED DRUG;

FEMALE; FOLLICULAR PHASE; HORMONE DETERMINATION; HUMAN; LUTEAL PHASE; MEDLINE; MENSTRUAL CYCLE; MENSTRUATION; OUTCOME VARIABLE; OVARY FUNCTION; PRIORITY JOURNAL; RELAPSE; REVIEW; SMOKING; SMOKING CESSATION; SYSTEMATIC REVIEW; WITHDRAWAL SYNDROME; ADULT; GENDER IDENTITY; META ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; WOMEN'S HEALTH;

ADULT; FEMALE; FOLLICULAR PHASE; GENDER IDENTITY; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; WOMEN'S HEALTH;

EID: 84929176370     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu249     Document Type: Review

References (92)

1. USDHHS. The health consequences of smoking-50 years of progress: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. WHO. WHO global report: mortality attributable to tobacco. Geneva, Switzerland: WHO Press; 2012.
3. Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. New Engl J Med. 2013;368:351-364.
4. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smokingcessation treatments in the United States. Am J Prev Med. 2008;34: 102-111.
5. CDC. Vital signs: current cigarette smoking among adults aged =18 years-United States, 2009. MMWR. 2010;59:1135-1140.
6. Perkins KA. Smoking cessation in women. Special considerations. CNS Drugs. 2001;15:391-411.
7. Perkins KA, Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res. 2008;10:1245-1250.
8. Piper ME, Cook JW, Schlam TR, et al. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob Res. 2010;12:647-657.
9. USDHHS. Women and smoking. A report of the Surgeon General. Rockville, MD: Department of Health and Human Services; 2001.
10. Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB. Gender differences in smoking cessation. J Consult Clin Psychol. 1999;67:555-562.
11. Killen JD, Fortmann SP, Varady A, Kraemer HC. Do men outperform women in smoking cessation trials? Maybe, but not by much. Exp Clin Psychopharmacol. 2002;10:295-301.
12. Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C, Pickworth WB. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol. 2007;15:21-36.
13. Pang RD, Leventhal AM. Sex differences in negative affect and lapse behavior during acute tobacco abstinence: a laboratory study. Exp Clin Psychopharmacol. 2013;21:269-276.
14. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Exp Clin Psychopharmacol. 2003;11:276-285.
15. Field M, Duka T. Cue reactivity in smokers: the effects of perceived cigarette availability and gender. Pharmacol Biochem Behav. 2004;78:647-652.
16. Niaura R, Shadel WG, Abrams DB, Monti PM, Rohsenow DJ, Sirota A. Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type. Addict Behav. 1998;23:209-224.
17. Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob Res. 2006;8:627-638.
18. Lynch WJ, Sofuoglu M. Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol. 2010;18:451-461.
19. Jackson LR, Robinson TE, Becker JB. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology. 2006;31:129-138.
20. Carroll ME, Lynch WJ, Roth ME, Morgan AD, Cosgrove KP. Sex and estrogen influence drug abuse. Trends Pharmacol Sci. 2004;25:273-279.
21. O'Dell LE, Torres OV. A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females. Neuropharmacology. 2014;76:566-580.
22. Torres OV, Natividad LA, Tejeda HA, Van Weelden SA, O'Dell LE. Female rats display dose-dependent differences to the rewarding and aversive effects of nicotine in an age-, hormone-, and sex-dependent manner. Psychopharmacology (Berl). 2009;206:303-312.
23. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71.
24. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P III. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther. 2006;79:480-488.
25. Strasser AA, Benowitz NL, Pinto AG, et al. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiol Biomarkers Prev. 2011;20:234-238.
26. Sofuoglu M, Herman AI, Nadim H, Jatlow P. Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine. Neuropsychopharmacology. 2012;37:1509-1516.
27. Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav. 2009;92:6-11.
28. Lynch WJ. Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats. Pharmacol Biochem Behav. 2009;94:43-50.
29. Lesage MG, Keyler DE, Burroughs D, Pentel PR. Effects of pregnancy on nicotine self-administration and nicotine pharmacokinetics in rats. Psychopharmacology (Berl). 2007;194:413-421.
30. Mello NK. Hormones, nicotine, and cocaine: clinical studies. Horm Behav. 2010;58:57-71.
31. Allen SS, Allen AM, Tosun N, Lunos S, al'Absi M, Hatsukami D. Smokingand menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptoms. Addict Behav. 2014;39:901-906.
32. Allen SS, Hatsukami D, Christianson D, Brown S. Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle. Nicotine Tob Res. 2000;2:231-241.
33. Hedges LV. Statistical methodology in meta-analysis. San Diego, CA: Academic Press; 1982.
34. Wolfgang V. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1-48.
35. Epperson CN, Toll B, Wu R, et al. Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. Drug Alcohol Depend. 2010;112:1-8.
36. Masson CL, Gilbert DG. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers. J Behav Med. 1999;22:589-604.
37. Perkins KA, Levine M, Marcus M, et al. Tobacco withdrawal in women and menstrual cycle phase. J Consult Clin Psychol. 2000;68:176-180.
38. DeVito EE, Herman AI, Waters AJ, Valentine GW, Sofuoglu M. Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase. Neuropsychopharmacology. 2014;39:1431-1440.
39. Allen SS, Allen AM, Kotlyar M, Lunos S, Al'absi M, Hatsukami D. Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence. Nicotine Tob Res. 2013;15:1091-1098.
40. Sakai H, Ohashi K. Association of menstrual phase with smoking behavior, mood and menstrual phase-associated symptoms among young Japanese women smokers. BMC Womens Health. 2013;13:10.
41. Schiller CE, Saladin ME, Gray KM, Hartwell KJ, Carpenter MJ. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012;20:251-257.
42. Mazure CM, Toll B, McKee SA, Wu R, O'Malley SS. Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug Alcohol Depend. 2011;114:68-72.
43. Sofuoglu M, Mouratidis M, Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology. 2011;36:123-132.
44. Allen AM, Allen SS, Lunos S, Pomerleau CS. Severity of withdrawal symptomatology in follicular versus luteal quitters: the combined effects of menstrual phase and withdrawal on smoking cessation outcome. Addict Behav. 2010;35:549-552.
45. Gray KM, DeSantis SM, Carpenter MJ, Saladin ME, LaRowe SD, Upadhyaya HP. Menstrual cycle and cue reactivity in women smokers. Nicotine Tob Res. 2010;12:174-178.
46. Allen SS, Allen AM, Lunos S, Hatsukami DK. Patterns of self-selected smoking cessation attempts and relapse by menstrual phase. Addict Behav. 2009;34:928-931.
47. Allen AM, Mooney M, Chakraborty R, Allen SS. Circadian patterns of ad libitum smoking by menstrual phase. Hum Psychopharmacol. 2009;24:503-506.
48. Allen AM, Allen SS, Widenmier J, Al'absi M. Patterns of cortisol and craving by menstrual phase in women attempting to quit smoking. Addict Behav. 2009;34:632-635.
49. Allen SS, Allen AM, Pomerleau CS. Influence of phase-related variability in premenstrual symptomatology, mood, smoking withdrawal, and smoking behavior during ad libitum smoking, on smoking cessation outcome. Addict Behav. 2009;34:107-111.
50. Sofuoglu M, Mitchell E, Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol. 2009;24:559-564.
51. Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Menstrual phase effects on smoking relapse. Addiction. 2008;103:809-821.
52. Carpenter MJ, Saladin ME, Leinbach AS, Larowe SD, Upadhyaya HP. Menstrual phase effects on smoking cessation: a pilot feasibility study. J Womens Health (Larchmt). 2008;17:293-301.
53. Franklin TR, Ehrman R, Lynch KG, et al. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt). 2008;17:287-292.
54. Franklin TR, Napier K, Ehrman R, Gariti P, O'Brien CP, Childress AR. Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob Res. 2004;6:171-175.
55. Sofuoglu M, Babb DA, Hatsukami DK. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol Biochem Be. 2001;69:299-304.
56. Pomerleau CS, Mehringer AM, Marks JL, Downey KK, Pomerleau OF. Effects of menstrual phase and smoking abstinence in smokers with and without a history of major depressive disorder. Addict Behav. 2000;25:483-497.
57. Snively TA, Ahijevych KL, Bernhard LA, Wewers ME. Smoking behavior, dysphoric states and the menstrual cycle: results from single smoking sessions and the natural environment. Psychoneuroendocrinology. 2000;25:677-691.
58. Marks JL, Pomerleau CS, Pomerleau OF. Effects of menstrual phase on reactivity to nicotine. Addict Behav. 1999;24:127-134.
59. Allen SS, Hatsukami DK, Christianson D, Nelson D. Withdrawal and pre-menstrual symptomatology during the menstrual cycle in short-term smoking abstinence: effects of menstrual cycle on smoking abstinence. Nicotine Tob Res. 1999;1:129-142.
60. Allen SS, Hatsukami D, Christianson D, Nelson D. Symptomatology and energy intake during the menstrual cycle in smoking women. J Subst Abuse. 1996;8:303-319.
61. DeBon M, Klesges RC, Klesges LM. Symptomatology across the menstrual cycle in smoking and nonsmoking women. Addict Behav. 1995;20:335-343.
62. Marks JL, Hair CS, Klock SC, Ginsburg BE, Pomerleau CS. Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and nonprescribed drugs in women with late luteal phase dysphoric disorder. J Subst Abuse. 1994;6:235-243.
63. Pomerleau CS, Cole PA, Lumley MA, Marks JL, Pomerleau OF. Effects of menstrual phase on nicotine, alcohol, and caffeine intake in smokers. J Subst Abuse. 1994;6:227-234.
64. Pomerleau CS, Garcia AW, Pomerleau OF, Cameron OG. The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report. Psychoneuroendocrinology. 1992;17:627-638.
65. Craig D, Parrott A, Coomber JA. Smoking cessation in women: effects of the menstrual cycle. Int J Addict. 1992;27:697-706.
66. O'Hara P, Portser SA, Anderson BP. The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addict Behav. 1989;14:595-600.
67. Steinberg JL, Cherek DR. Menstrual cycle and cigarette smoking behavior. Addict Behav. 1989;14:173-179.
68. Melllo NK, Mendelson JH, Palmieri SL. Cigarette smoking by women: interaction with alcohol use. Psychopharmacology. 1987;93:8-15.
69. Allen AM, al'Absi M, Lando H, Hatsukami D, Allen SS. Menstrual phase, depressive symptoms, and allopregnanolone during short-term smoking cessation. Exp Clin Psychopharmacol. 2013;21:427-433.
70. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3:7-16.
71. Tiffany ST, Drobes DJ. The development and initial validation of a questionnaire on smoking urges. Br J Addict. 1991;86:1467-1476.
72. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43:289-294.
73. Shiffman SM, Jarvik ME. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berl). 1976;50:35-39.
74. Franklin TR, Allen SS. Influence of menstrual cycle phase on smoking cessation treatment outcome: a hypothesis regarding the discordant findings in the literature. Addiction. 2010;104:1941-1942.
75. Saladin ME, McClure EA, Baker N, et al. Increasing progesterone levels are associated with smoking abstinence in free cycling women smokers receiving brief pharmacotherapy. Nicotine Tob Res. (this issue).
76. Piasecki TM. Relapse to smoking. Clin Psychol Rev. 2006;26:196-215.
77. Weinberger AH, Pilver CE, Mazure CM, McKee SA. Stability of smoking status in the US population: a longitudinal investigation. Addiction. 2014;109:1541-1553.
78. Genazzani AR, Petraglia F, Bernardi F, et al. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab. 1998;83:2099-2103.
79. Thakre PP, Tundulwar MR, Chopde CT, Ugale RR. Neurosteroid allopregnanolone attenuates development of nicotine withdrawal behavior in mice. Neurosci Lett. 2013;541:144-149.
80. Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. National Health Statistics Reports, no. 60. Hyattsville, MD: National Center for Health Statistics; 2012.
81. Berlin I, Gasior MJ, Moolchan ET. Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers. Nicotine Tob Res. 2007;9:493-498.
82. Grossman MP, Nakajima ST. Menstrual cycle bleeding patterns in cigarette smokers. Contraception. 2006;73:562-565.
83. Park J, Middlekauff HR. Altered pattern of sympathetic activity with the ovarian cycle in female smokers. Am J Physiol Heart Circ Physiol. 2009;297:H564-H568.
84. Whitcomb BW, Bodach SD, Mumford SL, et al. Ovarian function and cigarette smoking. Paediatr Perinat Epidemiol. 2010;24:433-440.
85. Gu F, Caporaso NE, Schairer C, et al. Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev. 2013;22:58-68.
86. Raval AP. Nicotine addiction causes unique detrimental effects on women's brains. J Addict Dis. 2011;30:149-158.
87. Allen EG, Sullivan AK, Marcus M, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22:2142-2152.
88. Santoro N, Brockwell S, Johnston J, et al. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause. 2007;14:415-424.
89. Caserta D, Bordi G, Di Segni N, D'Ambrosio A, Mallozzi M, Moscarini M. The influence of cigarette smoking on a population of infertile men and women. Arch Gynecol Obstet. 2013;287:813-818.
90. Plante BJ, Cooper GS, Baird DD, Steiner AZ. The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years. Menopause. 2010;17:571-576.
91. Gold EB. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am. 2011;38:425-440.
92. Sammel MD, Freeman EW, Liu Z, Lin H, Guo W. Factors that influence entry into stages of the menopausal transition. Menopause. 2009;16:1218-1227.